Atlas Trials

FX-322 in Adults With Stable Sensorineural Hearing Loss

Clinical trial NCT04120116 · COMPLETED

Trial details

NCT number
NCT04120116
Sponsor
Frequency Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss
Start date
2019-10-04
Primary completion
2020-10-06
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.